Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.

ClinicalTrials.gov ID: NCT03747939

Public ClinicalTrials.gov record NCT03747939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Early, Oligoarticular Psoriatic Arthritis Despite Initial Stable Treatment With Either NSAIDS and/or ≤ 1 Conventional Synthetic DMARD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical study will test the effects of a drug called apremilast in oligoarticular psoriatic arthritis with less than 5 years of disease duration. In previous studies, apremilast has been shown to be safe and efficacious in reducing signs and symptoms of psoriatic arthritis, as well as improving physical function. This study will compare the effects of apremilast to placebo on psoriatic arthritis subjects in which the number of affected joints is limited (greater than 1 but less or equal to 4). About 285 patients worldwide will take part in this study.

Study identification

NCT ID
NCT03747939
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
310 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2018 (Actual)
Primary completion
Dec 19, 2022 (Actual)
Completion
Jul 5, 2023 (Actual)
Last update posted
Sep 11, 2026

2018 – 2023

United States locations

U.S. sites
54
U.S. states
24
U.S. cities
51
Facility City State ZIP Site status
Arizona Arthritis and Rheumatology Research, PLLC Mesa Arizona 85202 —
Covina Arthritis Clinic Covina California 91722 —
Encino Research Center Encino California 91436 —
Providence Medical Foundation Fullerton California 92835 —
Rheumatology Center of San Diego PC San Diego California 92128 —
East Bay Rheumatology Medical San Leandro California 94578 —
Millennium Clinical Trials Thousand Oaks California 91360 —
Robin K Dore MD Inc Tustin California 92780 —
Inland Rheumatology Clinical Trials Inc Upland California 91786 —
Denver Arthritis Clinic PC Denver Colorado 80230 —
Arthritis and Rheumatic Disease Specialties Aventura Florida 33180 —
Clinical Research of West Florida, Inc Clearwater Florida 33765 —
Center for Rheumatology, Immunology, and Arthritis Fort Lauderdale Florida 33309 —
University of Florida College of Medicine Gainesville Florida 32610 —
Integral Rheumatology and Immunology Specialists Plantation Florida 33324 —
Florida Center For Dermatology Saint Augustine Florida 32080 —
Clinical Research of West Florida Inc Tampa Florida 33606-1246 —
Carol and Frank Morsani Center for Advanced Health Care Tampa Florida 33612 —
Baycare Medical Group Inc Tampa Florida 33614 —
North Georgia Rheumatology Group PC Lawrenceville Georgia 30046 —
RC Rsearch Inc Hinsdale Illinois 60521 —
OrthoIllinois Rockford Illinois 61114 —
Graves Gilbert Clinic Bowling Green Kentucky 42101 —
Clinical Trials Management LLC Metairie Louisiana 70006 —
Klein and Associates MD, PA - Cumberland Cumberland Maryland 21502 —
Klein and Associates MD PA Hagerstown Maryland 21740 —
Clinical Pharmacology Study Group Worcester Massachusetts 01605 —
Advanced Rheumatology PC Lansing Michigan 48910 —
Arthritis and Rheumatology Center of Michigan Lansing Michigan 48910 —
Clinical Research Institute of Michigan Saint Clair Shores Michigan 48081 —
Saint Paul Rheumatology PA Eagan Minnesota 55121 —
Arthritis, Rheumatic, and Back Disease Associates Voorhees Township New Jersey 08043 —
New York University Langone Medical Center New York New York 10003 —
University of Rochester Rochester New York 14642 —
Joint and Muscle Research Institute Charlotte North Carolina 28204 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Paramount Medical Research and Consulting LLC Middleburg Heights Ohio 44130 —
Arthritis and Osteoporosis Center of Southwest Ohio Middletown Ohio 45044 —
Health Research of Oklahoma Oklahoma City Oklahoma 73103 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Arthritis Group Philadelphia Pennsylvania 19152 —
Rhode Island Hospital Providence Rhode Island 02903 —
Piedmont Arthritis Clinic Greenville South Carolina 29601 —
West Tennessee Research Institute, llc Jackson Tennessee 38305 —
Accurate Clinical Research Incorporated Baytown Baytown Texas 77521 —
Precision Comprehensive Clinical Research Solutions Colleyville Texas 76034 —
Texas Arthritis Center PA El Paso Texas 79902 —
West Texas Clinical Research Lubbock Texas 79410 —
Advanced Rheumatology of Houston The Woodlands Texas 77382 —
Center for Clinical Studies Webster Texas 92103 —
Seattle Rheumatology Associates Seattle Washington 98104 —
Rheumatology and Pulmonary Clinic Beckley West Virginia 25801 —
West Virginia Research Institute Morgantown West Virginia 26505 —
West Virginia Research Institute South Charleston West Virginia 25309 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03747939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03747939 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →